Skip to main navigation Skip to search Skip to main content

Gain of Function of Malate Dehydrogenase 2 and Familial Hyperglycemia

  • Prapaporn Jungtrakoon Thamtarana
  • , Antonella Marucci
  • , Luca Pannone
  • , Amélie Bonnefond
  • , Serena Pezzilli
  • , Tommaso Biagini
  • , Patinut Buranasupkajorn
  • , Timothy Hastings
  • , Christine Mendonca
  • , Lorella Marselli
  • , Rosa Di Paola
  • , Zuroida Abubakar
  • , Luana Mercuri
  • , Federica Alberico
  • , Elisabetta Flex
  • , Julian Ceròn
  • , Montserrat Porta-De-La-Riva
  • , Ornella Ludovico
  • , Massimo Carella
  • , Simone Martinelli
  • Piero Marchetti, Tommaso Mazza, Philippe Froguel, Vincenzo Trischitta, Alessandro Doria, Sabrina Prudente
  • Harvard Medical School
  • Department of Medical Sciences
  • The Bambino Gesu Children’s Research Hospital Holy See
  • Institut Pasteur de Lille
  • University of Lille
  • Imperial College London
  • University “G. D'Annunzio”
  • Università di Pisa
  • Siriraj Hospital
  • Italian National Institute of Health
  • IDIBELL
  • Sapienza University of Rome

Research output: Contribution to journal › Article › peer-review

14 Citations (Scopus)

Abstract

Context: Genes causing familial forms of diabetes mellitus are only partially known. Objective: We set out to identify the genetic cause of hyperglycemia in multigenerational families with an apparent autosomal dominant form of adult-onset diabetes not due to mutations in known monogenic diabetes genes. Methods: Existing whole-exome sequencing (WES) data were used to identify exonic variants segregating with diabetes in 60 families from the United States and Italy. Functional studies were carried out in vitro (transduced MIN6-K8 cells) and in vivo (Caenorhabditis elegans) to assess the diabetogenic potential of 2 variants in the malate dehydrogenase 2 (MDH2) gene linked with hyperglycemia in 2 of the families. Results: A very rare mutation (p.Arg52Cys) in MDH2 strongly segregated with hyperglycemia in 1 family from the United States. An infrequent MDH2 missense variant (p.Val160Met) also showed disease cosegregation in a family from Italy, although with reduced penetrance. In silico, both Arg52Cys and Val160Met were shown to affect MDH2 protein structure and function. In transfected HepG2 cells, both variants significantly increased MDH2 enzymatic activity, thereby decreasing the NAD+/NADH ratio - a change known to affect insulin signaling and secretion. Stable expression of human wild-type MDH2 in MIN6-K8 cell lines enhanced glucose- and GLP-1-stimulated insulin secretion. This effect was blunted by the Cys52 or Met160 substitutions. Nematodes carrying equivalent changes at the orthologous positions of the mdh-2 gene showed impaired glucose-stimulated insulin secretion. Conclusion: Our findings suggest a central role of MDH2 in human glucose homeostasis and indicate that gain of function variants in this gene may be involved in the etiology of familial forms of diabetes.

Original languageEnglish
Pages (from-to)668-684
Number of pages17
JournalJournal of Clinical Endocrinology and Metabolism
Volume107
Issue number3
DOIs
Publication statusPublished - 1 Mar 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Krebs cycle
  • autosomal dominant diabetes
  • gene mutation
  • glucose homeostasis
  • insulin secretion
  • monogenic diabetes

Fingerprint

Dive into the research topics of 'Gain of Function of Malate Dehydrogenase 2 and Familial Hyperglycemia'. Together they form a unique fingerprint.

Cite this